Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT03974243 · COMPLETED
Trial details
- NCT number
- NCT03974243
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-11
- Primary completion
- 2021-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.